Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004971029 | SCV005495734 | uncertain significance | Inborn genetic diseases | 2024-11-28 | criteria provided, single submitter | clinical testing | The c.1193A>G (p.Y398C) alteration is located in exon 12 (coding exon 10) of the SETD5 gene. This alteration results from a A to G substitution at nucleotide position 1193, causing the tyrosine (Y) at amino acid position 398 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |